|
|
Other links at Articles > Cardiology |
| 3. |
Risk Factors Identified for Sudden Death in Myotonic Dystrophy Type 1
|
|
|
A 10-year study of adult patients with myotonic dystrophy type 1 confirms their high risk for arrhythmias and sudden death, and identifies factors that appear to predict high risk: patients with severe abnormalities on ECG and atrial tachyarrhythmias had a 3.5- and 5-fold increased risk respectively. Medscape Medical News
|
| 4. |
FDA Grants Additional Indication for Rosuvastatin
|
|
|
AstraZeneca has gained an additional indication in the US for rosuvastatin, as an adjunct to diet to slow the progression of atherosclerosis in patients with elevated cholesterol. Doctors will now have the option of prescribing rosuvastatin to those with a 10-year Framingham risk of less than 10%; such patients usually just receive advice on lifestyle interventions. Heartwire
|
|
|
